- Home
- Media Mentions
Our research mentioned in the media
- January 2022 (re CEP290-LCA)
- Gilmore Health News: Sepofarsen a Wonder Drug That Reverses Blindness in a Single Shot
- December 2021 (re CEP290-LCA)
- July 2021 (re Retinal gene therapy)
- Retina Today: Let’s talk about gene therapy for inherited retinal diseases
- New Retina Radio Podcast: The Latest on Gene Therapy for Inherited Retinal Diseases
- Retina Today: Let’s talk about gene therapy for inherited retinal diseases
- April 2021 (re GUCY2D-LCA)
- European Pharmaceutical Review: Novel blindness gene therapy shows promise in first-in-human trial
- News Medical: Gene therapy for common forms of congenital blindness shows promise to improve vision
- Health IT Analytics: Precision medicine therapy improves congenital blindness
- Penn News: Gene therapy shows promise in initial trial for patients with childhood blindness
- FFB: Encouraging early report for three patients in LCA1-GUCY2D gene therapy clinical trial
- April 2021 (re CEP290-LCA)
- Drug Discovery & Development: How ProQR aims to use RNA therapy to target genetic forms of blindness
- Drug Discovery & Development: Investigational drug gives sight to patient with inherited form of blindness
- The Ophthalmologist: Expanding tunnel vision
- ProQR: ProQR announces publication in Nature Medicine for sepofarsen in Leber congenital amaurosis 10
- Freethink: Penn scientists correct genetic blindness with a single injection into the eye
- The Daily Pennsylvanian: Penn Medicine researchers successfully test experimental therapy to reverse blindness
- Ophthalmology Times: In clinical trial, injection improves vision in a form of childhood blindness
- The Hill: Single shot of this groundbreaking drug reversed patient's blindness
- Science Times: Gene therapy gives vision to visually impaired patients since childhood, study reveals
- GEN: Mutation-specific RNA therapy can improve vision with lasting effects
- UNILAD: Experimental shot restored blind child’s vision for a year
- Futurism.com: Gene therapy injected into eyeball restores blind patient's vision
- Clinical Omics: Genetically-caused blindness reversed with single injection of antisense therapeutic
- Penn News: A single injection reverses blindness in patient with rare genetic disorder
- March 2021 (re NPHP5-LCA)
- The Ophthalmologist: Reversing LCA?
- NEI: Turning back the clock on a severe vision disorder
- Penn News: Turning back the clock on a severe vision disorder
- July 2020 (re RHO-ADRP)
- May 2020 (re RPGR-XLRP)
- March 2020
- September 2019 (re RPE65-LCA)
- Penn News: Is treatment forever? Success of gene therapy for inherited blindness depends on timing.
- EurekAlert: Success of gene therapy for a form of inherited blindness depends on timing
- docwire: Effectiveness of gene therapy for blindness depends on timing
- OT: Timing key in administering gene therapy
- January 2019 (re CEP290-LCA)
- The Ophthalmologist: From Darkness
- MD Magazine: Early gene therapy trials for retina disorder yield promise
- December 2018 (re CEP290-LCA)
- Penn Medicine News: Injection improves vision in a form of childhood blindness
- ProQR Therapeutics: ProQR announces publication in Nature Medicine of QR-110 data for Leber’s congenital amaurosis 10
- GEN: Injectable RNA therapy dramatically improves vision in child blindness
- UCL: Childhood blindness therapy shows 'very promising' results
- OT: From light perception to letters: patient’s vision improves following gene therapy
- December 2018 (re BEST1-ARB)
- Scheie Eye Institute: Correcting macular degeneration with gene therapy: Canine models and human implications
- October 2018
- August 2018 (re RHO-ADRP)
- Penn News: Knockdown and replace: A gene therapy twofer to treat blindness
- NIH NEI: Researchers find potential new gene therapy for blinding disease: Scientists funded by NIH preserve vision in dogs with a disease similar to retinitis pigmentosa in humans
- Philadelphia Inquirer: Penn’s experimental gene therapy saves night vision in dogs, paving the way for human tests
- UPI: New gene therapy treats inherited eye disorders in animal study
- Ophthotec: Scientific data for novel adeno-associated virus gene therapy in rhodopsin-mediated autosomal dominant retinitis pigmentosa published in Proceedings of the National Academy of Sciences
- June 2018
- April 2018
- March 2018 (re BEST1-ARB)
- Penn News: New gene therapy corrects a form of inherited macular degeneration in canine model
- GEN: Gene-therapy trials for inherited form of blindness could start in two years
- Technology Networks: Best disease blindness bettered by gene therapy
- BPoD: Blind spot
- FFB: Best disease gene therapy advances toward clinical trial
- December 2017
- November 2017
- August 2017
- August 2016
- December 2015
- BPoD: Battling Blindness
- October 2015 (re RPGR-XLRP)
- NEI News: Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
- Penn News: Penn Study Stops Vision Loss in Late-stage Canine X-linked Retinitis Pigmentosa
- Scicasts: Study Stops Vision Loss in Late-stage Canine X-linked Retinitis Pigmentosa
- FFB News: XLRP Gene Therapy Rescues Vision in Late-Stage Disease
- May 2015 (re RPE65-LCA)
- Sept 2014
- Nature News: Curing blindness: Vision quest
- March 2014
- January 2013
- January 2012
- August 2011
- December 2009
- September 2009
- Philadelphia Inquirer: New Implants Allow a Ray of Hope for Blind Patients
- August 2009
- EurekAlert: Vision Improvement after Gene Therapy Maintained at 1 Year for Inherited Retinal Blindness
- MIT Technology Review: Gene Therapy Creates a New Fovea
- EurekAlert: Vision Researchers See Unexpected Gain a Year into Blindness Trial
- September 2008
- November 2007
- June 2007
- May 2006
- April 2001